Remove Chronic Pain Remove Consumption Remove DEA Remove Epilepsy
article thumbnail

Veriheal’s Innovation in Cannabis Scholarship 2020 Winners

Veriheal

Essay Summary: Nishtha wants to further research into THC treatment for patients suffering from neurodegenerative diseases like Alzheimer’s and epilepsy , both of which cause neuron death. Supply chains are disrupted as a result, and consumers grow fearful of buying hemp. Personal data and information would be anonymous.

article thumbnail

What is THC? Here’s everything you need to know

The Cannigma

Marijuana (defined in the US as any cannabis plant where THC>0.3%) is a schedule I drug according to the DEA and FDA. Here are some factors that can influence your experience: other cannabinoids and terpenes the consumption method you prefer your own unique biological makeup. Potential risks of THC.

THC 98
article thumbnail

GW Pharmaceuticals Wins the Queens Prize for Innovation

SpeedWeed

Rather than going head-to-head with other well-funded competitors in some US state auction while facing down the DEA or buying out a patient collective or two in Canada, the process was a bit simpler. However, for most of its existence, the company produced products not for domestic consumption, but rather for export.